Investor Relations


Last $ 121.56
Change 1.78%
09.29.16 2:19 PM ET


LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Wed, 28 Sep, 2016 - 11:35 AM ET
Listen to Webcast »

Note: Alexion Pharmaceuticals, Inc. provides this data for informational and research purposes only. The data is not intended for trading purposes. Neither Alexion nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.